Efficacy and Safety of Vunakizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, placebo-controlled phase 3 trial
J Am Acad Dermatol 2024 Sep 25;[EPub Ahead of Print], K Yan, F Li, X Bi, L Han, Z Zhang, R Chen, Y Li, L Zhang, X Wang, L Li, J Lu, A Xu, S Yang, Y Lu, J Sun, Z Li, X Zhu, M Jiang, S Zhang, W Wang, Y Li, Z Meng, H Li, K Mou, X Han, S Li, A Chen, X Li, D Liu, C Zhang, C Ji, Y Wang, H Cheng, X Cui, X Yao, X Bai, G Dong, J XuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.